Seeking Alpha

Neostem unit names two senior managers

  • NeoStem (NBS) unit Progenitor Cell Therapy adds a couple of execs, appointing Robert Shaw as VP of Commercial Sales and Brian Hampson as Senior Director of a new department called Engineering & Innovation.
  • Shaw has held several positions at EMD Millipore, a supplier to the life science industry, while Hampson worked at Michigan-based Aastrom Biosciences for the last two decades. (PR)
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Tools
Find the right ETFs for your portfolio:
Seeking Alpha's new ETF Hub
ETF Investment Guide:
Table of Contents | One Page Summary
Read about different ETF Asset Classes:
ETF Selector